From Hypothesis to Action: Breeding for TYM Resistance
The Hidden Architecture of Cannabis: A 4-Part Series on Phenotype-Dependent Microbial Resistance
By Christopher Leavitt, Founder, Voyager Genetics
Photograph by Craig Burrows
We've spent three parts building a case: that cultivar genotype is a significant driver of Total Yeast and Mold outcomes, that “anti-aircraft defense” (preventing spore deposition through active transpiration and flower architecture) is likely the primary mechanism, and that understanding this mechanism opens entirely new possibilities for how breeders select cannabis genetics.
Now comes the harder question: what do we actually do with this?
The answer is not "wait for perfect mechanistic understanding." The answer is what breeders have always done- observe, test, adapt, and iterate based on real-world data. We don't need to fully understand why open architecture resists TYM to start selecting for it. We just need to measure it, track it, and let the data guide breeding decisions.
Step 1: Keep Records
The most obvious step is also the most overlooked. For cultivators, the foundation of any meaningful TYM-resistant breeding program starts with data retention and analysis.
Most facilities run TYM tests as a compliance requirement. They get the result, they pass or fail, and the data disappears. The best cultivators are systematically tracking which cultivars consistently test low, which consistently test high, and how that pattern holds across multiple growing cycles and seasons.
That data is gold. If you're a licensed medical producer, start retaining your TYM results organized by cultivar. Track them across multiple harvest cycles. Begin to see which genetics reliably pass, which reliably fail, and which show concerning variability. This isn't a formal research project, it's basic record-keeping that reveals patterns you're currently missing.
For cultivars that consistently test low across cycles, even under different environmental conditions, you're looking at a phenotype worth investigating further. For cultivars that consistently fail, you have your answer about whether to continue with that line.
The pattern of cultivar-specific TYM consistency is the entire premise of this series. You likely already have that data. You just haven't organized it yet.
Step 2: Industry Partnerships and Data Sharing
Here's the limitation that most breeders won't acknowledge: I don't know of any breeding outfit that has the capability to meaningfully test for TYM resistance themselves in a way that feeds breeding decisions.
TYM testing is expensive. It requires licensed laboratory infrastructure, compliance adherence, and turnaround times measured in days. A small breeding operation can't economically run TYM tests on every candidate line during phenotyping. And without that data flowing directly into breeding decisions, you're selecting blind on TYM. This is also a commercialization problem fundamentally, not an R+D one. Good TYM resistance in your test grow might not translate well to the commercial setting.
This is why industry partnerships are essential.
At Voyager, we depend on our ecosystem of partners: cultivation facilities with GACP compliance, regulatory infrastructure, and the ability to run repeated testing cycles to work together on cultivar development. This is not a solitary breeding exercise. It cannot be. The genetics development happens in collaboration with operators who have the infrastructure to generate the data that matters.
What makes this moment unique, is expanding those partnerships to include systematic TYM data sharing and deliberate breeding decisions based on that data.
We're asking: "How does this cultivar perform across multiple TYM cycles? Are there patterns? Which phenotypes consistently test low? Which show the architecture we've been discussing?"
That data flows back into breeding decisions. We lean toward the phenotypes that show TYM resistance. We investigate the architectural traits they share. We use that information to inform which genetics we phenohunt, which lines we prioritize for commercialization, and which breeding crosses we pursue.
This isn't a future plan. This is being implemented right now. Our communication and coordination with partners to identify TYM-resistant phenotypes and deliberately breed toward those characteristics is already part of our action plan because of how essential it has become.
The facilities and breeders who ignore TYM as a formal breeding target will be at a significant competitive disadvantage in a market where microbial compliance is increasingly stringent and increasingly expensive.
Step 3: Research Opportunities- The Missing Pieces
For all the progress we've made in understanding TYM resistance, there are enormous gaps in our actual knowledge. Filling those gaps requires research infrastructure and resources that individual breeders and cultivators don't have access to.
Microscopy and deposition studies could be transformative. Taking actual cannabis flowers from high-TYM and low-TYM cultivars, subjecting them to measured spore deposition under controlled conditions, and then recording how many particles actually land…that would directly test the anti-aircraft hypothesis we've been building. Does a low-TYM cultivar genuinely experience lower spore deposition? Or is the TYM difference driven entirely by factors that happen after landing? That single study could rewrite everything we think we know about what matters.
Deep analysis of the TYM assay itself is another critical gap. The Punja study noted that the current TYM testing protocol cannot distinguish between pathogenic, beneficial, and benign organism- it just counts everything. But different organisms matter differently. A cultivar might show high TYM because it's accumulating harmless environmental yeasts while resisting pathogenic molds. Or vice versa. The assay's blindness to these distinctions means we're optimizing for the wrong thing.
There's also the fundamental question of what actually drives TYM outcomes: is it primarily about cultivation conditions and post-harvest handling, or is genotype the dominant variable? The Punja study addressed this empirically, but the deeper mechanistic research hasn't been done. How much does HVAC design influence TYM relative to cultivar choice? How much does the timing of harvest matter? How much does surface colonization versus endogenous infection actually contribute to the final count?
These are foundational questions with practical implications for facility design, breeding strategy, and regulatory standards. And right now, we're operating with incomplete answers.
The research agenda is clear: cannabis needs dedicated institutions studying microbial ecology, deposition dynamics, and the relationship between plant architecture and spore accumulation. Universities like Guelph, which has established cannabis research infrastructure, or other institutions with medical cannabis programs, are positioned to do this work. The questions are scientifically interesting, practically urgent, and currently underfunded.
Step 4: R&D-Scale TYM Testing
One barrier to accelerating TYM-resistant breeding is cost. TYM testing is expensive enough that most breeders can't afford to run it during phenotyping or on R&D batches. This creates an information desert at the exact moment when data would be most valuable- during the early selection process when you're deciding which phenotypes deserve to be multiplied and commercialized.
An analogous but less rigorous TYM assay which is faster, cheaper, capable of delivering directional data if not compliance-grade accuracy could be game-changing. The ability to run TYM testing during phenotyping, or at least on early R&D batches, would let breeders make informed decisions about which lines to push forward and which to cull.
This doesn't replace compliance-grade testing. It augments it. It gives you early signal about cultivar performance so you can make breeding decisions with better information.
Developing and validating a simplified TYM protocol that still provides meaningful data, but at a fraction of the cost, is another research opportunity worth pursuing. Not for regulatory compliance, but for breeding iteration.
Step 5: The Bigger Picture — Facility Design and Breeding as Systems
If cultivar selection significantly impacts TYM outcomes, it changes how we think about facility design and environmental control.
For years, the assumption has been that TYM is primarily an environmental problem, something you solve through HVAC, humidity control, sanitation protocols, and facility design. That's not wrong. But if phenotype is a significant independent variable, it's incomplete.
A facility optimized for low-TYM cultivars might have entirely different HVAC and humidity specifications than one optimized for high-TYM genetics. The cultivar you choose constrains the facility design you need. The facility design you choose constrains which cultivars are viable.
This isn't a novel insight in agriculture- crop selection and facility design are always intertwined. But for cannabis, it's a relatively new consideration. Most facilities were designed around environmental control assumptions without factoring in cultivar-specific traits.
That changes the economics and the strategy. A facility that selects for TYM-resistant cultivars from the start might operate more efficiently, require less aggressive environmental control, and face lower remediation costs. A facility that ignores cultivar TYM performance will be fighting an uphill battle no matter how well-designed the HVAC is.
What This Means For You
If you're a breeder: start tracking TYM data from your crosses. Partner with cultivation facilities that can generate that data. Use it to inform which phenotypes you advance, which lines you commercialize, and which breeding crosses you prioritize. You don't need perfect mechanistic understanding to start selecting. You just need to measure and adapt.
If you're a cultivator: retain your TYM data organized by cultivar. Look for patterns. Communicate those patterns back to your genetics suppliers. Demand cultivars selected for TYM resistance, not just cannabinoid profile or aroma. Your facility's microbial compliance burden is directly tied to the genetics you choose.
If you're a researcher: this is your moment. The questions are clear. The industry is ready. The funding should follow. Study deposition dynamics. Validate simplified testing protocols. Map the relationship between facility design and cultivar performance. This is foundational work for a maturing industry.
The Moment We're In
We're at an inflection point in cannabis breeding. For decades, selection has operated within a relatively narrow set of constraints: cannabinoid profile, terpene expression, yield, disease resistance, flowering time. TYM was something you managed post-harvest, not something you bred for.
Now, as medical cannabis markets tighten their microbial specifications and as remediation costs climb, TYM is becoming a primary breeding target. Not an afterthought. Not a compliance checkbox. A genuine phenotype worth selecting for, worth studying, worth investing in.
Breeders and cultivators who recognize this shift and begin incorporating TYM resistance into their selection criteria now will have significant advantages in markets where microbial compliance is increasingly stringent. Those who ignore it will be playing catch-up in a few years.
This is the work we're doing at Voyager.
It's not perfect science yet. But it doesn't need to be. It just needs to be better than the alternative, which is waiting for perfect understanding while the market moves forward without you.
Observe. Test. Adapt. That's what breeders do. And right now, TYM resistance is one of the most important things we're observing, testing, and adapting toward.
Christopher Leavitt is the founder of Voyager Genetics, a cannabis genetics IP licensing and consulting company based in Lisbon, Portugal. Voyager supplies GACP-compliant, phenohunted clone genetics to licensed medical cannabis producers across Europe. We are actively incorporating TYM resistance into our breeding program and welcome partnerships with cultivation facilities interested in contributing to this research.
Further reading:
Punja, Z.K., Ni, L., Lung, S., and Buirs, L. (2023). Total yeast and mold levels in high THC-containing cannabis (Cannabis sativa L.) inflorescences are influenced by genotype, environment, and pre- and post-harvest handling practices. Frontiers in Microbiology, 14:1192035. https://doi.org/10.3389/fmicb.2023.1192035
